SPAG9 controls the cell motility, invasion and angiogenesis of human osteosarcoma cells

X Yang, W Zhou, S Liu - Experimental and Therapeutic …, 2016 - spandidos-publications.com
Abstract Sperm‑associated antigen 9 (SPAG9) is an oncoprotein involved in the progression
of various human malignancies; however, its role in osteosarcoma (OS) remains poorly …

Раковые тестикулярные антигены в иммунотерапии злокачественных опухолей

ДИ Водолажский, ОИ Кит, ХА Могушкова… - Сибирский …, 2017 - cyberleninka.ru
Низкая токсичность, онкоспецифичность, иммуногенность и относительно частая
экспрессия во многих типах рака СТ-антигенов послужили основанием для их …

[HTML][HTML] JLP/Foxk1/N-cadherin axis fosters a partial epithelial-mesenchymal transition state in epithelial tubular cells

M Tian, L Zhang, M Zhang, L Qiao, B Xu, C Li, S Liu… - Iscience, 2023 - cell.com
Renal tubular epithelial cells (TECs) undergoing partial epithelial-mesenchymal transition
(pEMT) during renal fibrosis has been recognized as a featuring and detrimental event …

Metastasis: a major driver of cancer pathogenesis

PS Cheema, G Kumar, S Mittal, D Parashar… - Drug Targets in Cellular …, 2020 - Springer
Cancer is a multifactorial condition that originates from genomic alterations in the cells,
which confer them the ability to evade various cellular regulations and proliferate …

Cisplatin reprogramming of protein phosphorylation

L Qi, Y Zhou, Y Hou, Q Luo, Y Xu, X Liu, W Yu, B Xin… - bioRxiv, 2024 - biorxiv.org
Cisplatin is a DNA-targeting chemotherapeutic. We have utilized a forward chemical
genetics strategy to map 7585 cisplatin-damaged genes (CDGs) with a fold-enrichment of> …

Sperm-associated antigen 9 is upregulated in hepatocellular carcinoma tissue and enhances QGY cell proliferation and invasion in vitro

B Ren, G Zou, J He, Y Huang, G Ma… - Oncology …, 2018 - spandidos-publications.com
The incidence and mortality rates of hepatocellular carcinoma (HCC) are higher in China
compared with in other countries. Further research is required in order to improve the …

[引用][C] 乳腺癌靶向治疗的分子基础

李静, 黄睿, 刘秀娟, 罗瑛, 杨举伦 - 生命的化学, 2014

Sperm-associated antigen 9 overexpression correlates with poor prognosis and insensitive to Taxol treatment in breast cancer

C Yang, B Shen, J Zhang, Q Zhang - Biomarkers, 2016 - Taylor & Francis
Abstract Sperm-associated antigen 9 (SPAG9) has been reported to express in several
cancers and have clinical significance. Using immunohistochemistry, we found that there …

Cell cycle arrest: an impending therapeutic strategy to curb cancer

G Kumar, S Mittal, D Parashar, K Jadhav… - Drug Targets in Cellular …, 2020 - Springer
Eukaryotic cell division is divided into several phases and each of these phases has their
own control mechanisms. Failure of any of these control mechanisms may lead to …

Oncolytic Adenovirus with SPAG9 shRNA Driven by DD3 Promoter Improved the Efficacy of Docetaxil for Prostate Cancer

M Lu, F Wei, C Wu, Z Xu, L Mao, D Yang - Journal of Oncology, 2022 - Wiley Online Library
Prostate cancer (PCa) is a common malignant tumor of the male urinary system and ranks
the second in the causes of tumor‐related deaths. Differential display code 3 (DD3) is a …